|
 |
 |
||||||||||
|
|||||||||||
 |
 |
1. Genetic Changes May Dictate Course of Acute Myeloid Leukemia
Findings could help determine which therapies will benefit certain patients Expand your search to include all of U.S. News
2. Medical Policies Online - Attachment A to 11.07.01c
Medical Policies Online - Attachment A to 11.07.01c. Anaplastic large cell lymphoma, unspecified site, extranodal and solid organ sites. Secondary malignant... http://medpolicy.ibx.com/policies/mpi.nsf/0dd9e970fee87af885256419005f920e/8525...
3. NEJM -- Measurement of Residual Leukemia during Remission in Childhood Acute Lymphoblastic Leukem...
Measurement of Residual Leukemia during Remission in Childhood Acute Lymphoblastic Leukemia. The European Organization for Research and Treatme, (1998) Clin... http://content.nejm.org/cgi/content/short/336/5/317?query=prevarrow
4. Farnesyl Transferase Inhibitor R115777 in Acute Myeloid Leukemia (AML) Patients in Second or Subs...
Men or women 18 years of age and older with Acute Myeloid Leukemia (AML) in second or subsequent remission or in remission after primary induction failure; ... http://clinicaltrials.mayo.edu/clinicaltrialdetails.cfm?trial_id=100347 |
advertisement |
- Subscriber Services |
- Site Map |
- About Us |
- Contact Us |
- Classroom Program |
- Marketplace |
- Store |
- Advertise With Us |
- Masthead
Use of this Web site constitutes acceptance of our Terms and Conditions of Use and Privacy Policy.